Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013
Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Ur...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Nefrologia
2014-12-01
|
Series: | Brazilian Journal of Nephrology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&lng=en&tlng=en |
id |
doaj-f82361229a3e4c5b8d9e8ee48b3b12ae |
---|---|
record_format |
Article |
spelling |
doaj-f82361229a3e4c5b8d9e8ee48b3b12ae2020-11-25T01:06:00ZengSociedade Brasileira de NefrologiaBrazilian Journal of Nephrology2175-82392014-12-0136451251810.5935/0101-2800.20140073S0101-28002014000400512Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013Lina Maria Serna HiguitaJohn Fredy Nieto-RíosSalomon Daguer-GonzalezCatalina Ocampo-KohnArbey Aristizabal-AlzateCatalina Velez-EcheverriJuan Jose Vanegas-RuizIsabel Ramirez-SanchezJhon Jairo Zuleta TobonGustavo Adolfo Zuluaga-ValenciaIntroduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&lng=en&tlng=enmycobacterium tuberculosisrejeição de enxertotransplante de rim |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Lina Maria Serna Higuita John Fredy Nieto-Ríos Salomon Daguer-Gonzalez Catalina Ocampo-Kohn Arbey Aristizabal-Alzate Catalina Velez-Echeverri Juan Jose Vanegas-Ruiz Isabel Ramirez-Sanchez Jhon Jairo Zuleta Tobon Gustavo Adolfo Zuluaga-Valencia |
spellingShingle |
Lina Maria Serna Higuita John Fredy Nieto-Ríos Salomon Daguer-Gonzalez Catalina Ocampo-Kohn Arbey Aristizabal-Alzate Catalina Velez-Echeverri Juan Jose Vanegas-Ruiz Isabel Ramirez-Sanchez Jhon Jairo Zuleta Tobon Gustavo Adolfo Zuluaga-Valencia Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 Brazilian Journal of Nephrology mycobacterium tuberculosis rejeição de enxerto transplante de rim |
author_facet |
Lina Maria Serna Higuita John Fredy Nieto-Ríos Salomon Daguer-Gonzalez Catalina Ocampo-Kohn Arbey Aristizabal-Alzate Catalina Velez-Echeverri Juan Jose Vanegas-Ruiz Isabel Ramirez-Sanchez Jhon Jairo Zuleta Tobon Gustavo Adolfo Zuluaga-Valencia |
author_sort |
Lina Maria Serna Higuita |
title |
Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 |
title_short |
Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 |
title_full |
Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 |
title_fullStr |
Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 |
title_full_unstemmed |
Tuberculosis in renal transplant patients: The experience of a single center in Medellín-Colombia, 2005-2013 |
title_sort |
tuberculosis in renal transplant patients: the experience of a single center in medellín-colombia, 2005-2013 |
publisher |
Sociedade Brasileira de Nefrologia |
series |
Brazilian Journal of Nephrology |
issn |
2175-8239 |
publishDate |
2014-12-01 |
description |
Introduction: Tuberculosis is a common opportunistic infection in renal transplant patients. Objective: To obtain a clinical and laboratory description of transplant patients diagnosed with tuberculosis and their response to treatment during a period ranging from 2005 to 2013 at the Pablo Tobón Uribe Hospital. Methods: Retrospective and descriptive study. Results: In 641 renal transplants, tuberculosis was confirmed in 12 cases. Of these, 25% had a history of acute rejection, and 50% had creatinine levels greater than 1.5 mg/dl prior to infection. The disease typically presented as pulmonary (50%) and disseminated (33.3%). The first phase of treatment consisted of 3 months of HZRE (isoniazid, pyrazinamide, rifampicin and ethambutol) in 75% of the cases and HZME (isoniazid, pyrazinamide, moxifloxacin and ethambutol) in 25% of the cases. During the second phase of the treatment, 75% of the cases received isoniazid and rifampicin, and 25% of the cases received isoniazid and ethambutol. The length of treatment varied between 6 and 18 months. In 41.7% of patients, hepatotoxicity was associated with the beginning of anti-tuberculosis therapy. During a year-long follow-up, renal function remained stable, and the mortality rate was 16.7%. Conclusion: Tuberculosis in the renal transplant population studied caused diverse nonspecific symptoms. Pulmonary and disseminated tuberculosis were the most frequent forms and required prolonged treatment. Antituberculosis medications had a high toxicity and mortality. This infection must be considered when patients present with a febrile syndrome of unknown origin, especially during the first year after renal transplant. |
topic |
mycobacterium tuberculosis rejeição de enxerto transplante de rim |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002014000400512&lng=en&tlng=en |
work_keys_str_mv |
AT linamariasernahiguita tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT johnfredynietorios tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT salomondaguergonzalez tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT catalinaocampokohn tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT arbeyaristizabalalzate tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT catalinavelezecheverri tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT juanjosevanegasruiz tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT isabelramirezsanchez tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT jhonjairozuletatobon tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 AT gustavoadolfozuluagavalencia tuberculosisinrenaltransplantpatientstheexperienceofasinglecenterinmedellincolombia20052013 |
_version_ |
1725192064843382784 |